Markets
-
HPE Supercomputer to Revolutionize New Zealand Environmental Forecasting with AI
Earth Sciences New Zealand has deployed the HPE Cray XD2000 supercomputing system, “Cascade,” significantly enhancing weather forecasting and environmental research. Replacing aging infrastructure, the system triples computational power using AMD’s 4th Gen EPYC processors and HPE GreenLake for File Storage (19 petabytes). Cascade’s direct liquid cooling minimizes energy consumption, aligning with sustainability goals. This upgrade enables more precise weather predictions, bolsters resilience against climate-related hazards, and positions New Zealand as a leader in HPC within the Asia Pacific region.
-
Maria Bartiromo to Feature NioCorp on September 25th
NioCorp Developments CEO Mark A. Smith will appear on Fox Business News on September 25, 2025, to discuss the Elk Creek Critical Minerals Project in Nebraska. This project is the only U.S. project containing niobium, scandium, titanium, and rare earths, and is fully permitted for construction. The U.S. relies heavily on niobium imports, crucial for advanced steels and defense, while Brazil controls most production, and China influences supply chains through mine ownership.
-
Lockheed Martin Vectis™: Unmatched Survivability in the CCA Class
Lockheed Martin’s Skunk Works has introduced Vectis, a Group 5 collaborative combat aircraft (CCA), designed to provide air dominance. Vectis integrates with existing aircraft, offering capabilities like precision strike and electronic warfare. Its open architecture promotes adaptability and affordability, leveraging advanced materials and digital engineering. Vectis aims for rapid deployment and is currently under development, emphasizing survivability, multi-role functionality, and alignment with evolving defense architectures, reflecting Lockheed Martin’s commitment to advanced, cost-effective defense solutions.
-
Patients Report Symptom Improvement and High Satisfaction with AUSTEDO XR® (deutetrabenazine) Extended-Release Tablets
Teva Pharmaceuticals presented positive real-world data on AUSTEDO XR® for tardive dyskinesia (TD) at the 2025 Psych Congress. A survey of 209 TD patients showed significant treatment satisfaction, with over 94% reporting movement improvement and over 89% expressing high overall satisfaction. Furthermore, 77% reported improved social comfort and emotional well-being, and 96% found the medication easy to take. 96% of patients expressed interest in continuing treatment.
-
Supreme Critical Metals Inc. Reports Stock Option Grants and Silver Vista Option Agreement Amendment
Supreme Critical Metals (VRCFF) announced the grant of 2,675,000 stock options to management, employees, and consultants at $0.22 per share, exercisable over 3 years. The company also amended its Silver Vista option agreement, opting to issue 500,000 shares at $0.17 per share and grant a 0.6% NSR to Robert Weicker instead of investing $100,000 in the property by December 31, 2025, pending CSE approval. These moves aim to strategically position the company within the metals market.
-
C4 Therapeutics Presents Promising Cemsidomide Phase 1 Data in Multiple Myeloma at IMS Annual Meeting
C4 Therapeutics announced positive Phase 1 results for cemsidomide in relapsed/refractory multiple myeloma. The drug demonstrated a 50% overall response rate at the highest dose, a favorable safety profile with no treatment discontinuations, and promising immunomodulatory effects. The company plans to initiate Phase 2 trials in Q1 2026 for fourth-line therapy and Phase 1b trials in Q2 2026 for second-line therapy in combination with BCMA BiTE, pursuing two potential accelerated approval pathways. The trial included 72 heavily pre-treated patients.
-
JI Hotel Expands to Malaysia and Cambodia, Boosting H World’s Southeast Asia Footprint
H World Group is expanding further into Southeast Asia with new JI Hotels in Kuala Lumpur and Phnom Penh. This marks H World’s entry into Malaysia and strengthens JI Hotel’s presence in the region. The Kuala Lumpur property is set to open in Q4 2026, while the Phnom Penh hotels are scheduled for Q2 and Q3 2026. This expansion is driven by growing demand in Southeast Asia’s hospitality sector and is part of H World’s broader strategy to leverage its complete ecosystem for growth in Asia Pacific.
-
Pony.ai and ComfortDelGro Partner to Launch Autonomous Vehicles in Singapore
Pony.ai is entering the Singaporean market in partnership with ComfortDelGro to launch autonomous vehicle (AV) services, initially in the Punggol district. This move aligns with Singapore’s smart mobility vision and aims to address driver shortages. The partnership builds on a previous MoU and a successful pilot program in Guangzhou. The Singaporean government supports AV integration, with plans to deploy AVs within public housing estates. Pony.ai currently operates driverless Robotaxi services in multiple Chinese cities and is expanding globally, including partnerships in Qatar and Luxembourg.
-
BioNxt Solutions Completes Shares for Debt Settlement
BioNxt Solutions (BNXTF) completed a debt settlement with an arm’s length creditor, settling a $225,010 debt via share issuance (112,505 shares at CAD$1.00) and a $112,505 cash payment. The newly issued shares are subject to a four-month and one-day holding period according to CSE policies. This move aims to strengthen financial footing while preserving cash for core operations, though it may result in minor shareholder dilution. BioNxt focuses on bioscience innovation, particularly drug delivery technologies.
-
Five Point: Tender Offer Results for 2028 Senior Notes
On September 19, 2025, Five Point Holdings, LLC announced the expiration of its cash tender offer for its 10.500% Senior Notes due 2028. A significant $471.5 million (over 90%) was tendered. Five Point expects to accept all validly tendered notes by September 23 and pay on September 25, funded by a new $450 million offering of 8.000% Senior Notes due 2030 and cash reserves. The move aims to streamline capital structure and reduce interest expense, allowing for future development.